- Home
- CRNX vs ESNT Comparison
CRNX vs ESNT Comparison
Compare CRNX & ESNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- ESNT
- Stock Information
- Founded
- CRNX 2008
- ESNT 2008
- Country
- CRNX United States
- ESNT Bermuda
- Employees
- CRNX N/A
- ESNT N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- ESNT Property-Casualty Insurers
- Sector
- CRNX Health Care
- ESNT Finance
- Exchange
- CRNX Nasdaq
- ESNT Nasdaq
- Market Cap
- CRNX 2.8B
- ESNT N/A
- IPO Year
- CRNX 2018
- ESNT 2013
- Fundamental
- Price
- CRNX $33.00
- ESNT $56.54
- Analyst Decision
- CRNX Strong Buy
- ESNT Buy
- Analyst Count
- CRNX 8
- ESNT 7
- Target Price
- CRNX $74.86
- ESNT $63.71
- AVG Volume (30 Days)
- CRNX 751.6K
- ESNT 779.5K
- Earning Date
- CRNX 08-07-2025
- ESNT 08-01-2025
- Dividend Yield
- CRNX N/A
- ESNT 2.21%
- EPS Growth
- CRNX N/A
- ESNT 3.49
- EPS
- CRNX N/A
- ESNT 6.84
- Revenue
- CRNX $760,000.00
- ESNT $1,262,105,000.00
- Revenue This Year
- CRNX $402.02
- ESNT $5.40
- Revenue Next Year
- CRNX $771.03
- ESNT $3.66
- P/E Ratio
- CRNX N/A
- ESNT $8.19
- Revenue Growth
- CRNX N/A
- ESNT 9.57
- 52 Week Low
- CRNX $24.10
- ESNT $51.61
- 52 Week High
- CRNX $62.53
- ESNT $65.34
- Technical
- Relative Strength Index (RSI)
- CRNX 57.94
- ESNT 34.11
- Support Level
- CRNX $28.98
- ESNT $60.34
- Resistance Level
- CRNX $32.49
- ESNT $61.94
- Average True Range (ATR)
- CRNX 1.24
- ESNT 1.06
- MACD
- CRNX 0.30
- ESNT -0.55
- Stochastic Oscillator
- CRNX 90.54
- ESNT 2.90
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.